News
Pfizer to Explore Strategic Alternatives for its Animal Health...
Pfizer Inc. (NYSE: PFE) is exploring strategic alternatives for its Animal Health and Nutrition businesses based on its recent business portfolio review to determine the...
News
Bristol-Myers Squibb and Innate Pharma Announce Breakthrough Global License...
Bristol-Myers Squibb Company (NYSE: BMY) and Innate Pharma S.A. (Euronext Paris: FR0010331421, IPH) announced a global agreement for the development and commercialization of IPH2102, a...
News
Amgen and UCB Team Up with NASA on Final...
Amgen (NASDAQ: AMGN) and UCB (Euronext Brussels: UCB) are collaborating with the National Aeronautics and Space Administration (NASA) Ames Research Center to conduct a preclinical...
News
Medical Research Council Finds Antibody Capable of Fighting Flu
An antibody that can fight all types of the influenza A virus has been identified by researchers from the Medical Research Council's National Institute for...
News
GlaxoSmithKline and Valeant announce US FDA approval of Potiga
GlaxoSmithKline and Valeant Pharmaceuticals International, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved Potigaâ„¢ (ezogabine) Tablets, a potassium channel opener, as...
News
Paladin And Elan Sign Agreement For New Pain Product
Paladin Labs Inc., a leading Canadian specialty pharmaceutical company, today announced that they have entered into a licensing and distribution agreement under which Paladin has...
News
Merck Statement Regarding FDA Approval of Changes to Trade...
Merck appreciates the U.S. Food and Drug Administration's (FDA) recognition of our efforts to create new standardized product packaging for several of our medicines. ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.